Diversey Holdings, Ltd. ("Diversey") (NASDAQ: DSEY) announces first
quarter results.
Unaudited |
First Quarter Ended March 31 |
(millions) |
|
2023 |
|
|
2022 |
|
% Change |
Net sales |
$ |
696.0 |
|
$ |
660.0 |
|
5.5 |
% |
Loss before taxes |
|
(44.3 |
) |
|
(37.2 |
) |
(19.1)% |
% Margin |
(6.4)% |
(5.6)% |
(80) bps |
Net loss |
|
(53.6 |
) |
|
(39.1 |
) |
(37.1)% |
Adjusted net income
(loss)(1) |
|
1.5 |
|
|
3.7 |
|
(59.5)% |
|
|
|
|
Adjusted EBITDA(1) |
|
52.6 |
|
|
60.3 |
|
(12.8)% |
% Margin(1) |
|
7.6 |
% |
|
9.1 |
% |
(150) bps |
(1) See the “Non-GAAP Financial Information and Segment Adjusted
EBITDA” section herein for explanations of these financial
measures.
First Quarter 2023 Consolidated Results
Net sales increased 5.5% versus prior year or 12.6% when
adjusting for currency, continuing positive momentum entering the
year. Each segment continues to win new customers while passing
through pricing to combat high cost inflation.
Loss before taxes of $44.3 million in the first quarter of 2023
included Special Items (as defined below) impact of $55.1 million
and compared to loss before taxes of $37.2 million in first quarter
2022 including Special Items impact of $42.8 million. Loss before
taxes margin declined 80 basis points compared to the same prior
year period. Adjusted EBITDA for the first quarter 2023 was $52.6
million, representing a decline of 12.8% versus the period in 2022
as reported or a decline of 0.8% when adjusting for currency.
Adjusted EBITDA margin declined 150 basis points compared to the
same period 2022. Growth from accelerating pricing was more than
offset by higher costs and foreign exchange pressures in the
period.
Net loss of $53.6 million for the first quarter of 2023
representing a decline of 37.1% versus the first quarter of 2022
with EPS of $(0.17) in the first quarter of 2023 compared to
$(0.12) in the first quarter of 2022. Adjusted net income in the
first quarter 2023 was $1.5 million compared to Adjusted net income
of $3.7 million in the first quarter 2022 with Adjusted EPS of
$0.00 in the first quarter 2023 compared to $0.01 in the first
quarter 2022.
Segment Review
Institutional
Unaudited |
First Quarter Ended March 31 |
(millions) |
|
2023 |
|
|
2022 |
|
% Change |
Net sales |
$ |
477.1 |
|
$ |
472.2 |
|
1.0 |
% |
Adjusted EBITDA |
|
37.6 |
|
|
53.0 |
|
(29.1)% |
% Margin |
|
7.9 |
% |
|
11.2 |
% |
(330) bps |
Net sales of $477.1 million in the Institutional segment were
1.0% above the first quarter of 2022 or 7.3% when adjusting for
currency. Growth in the quarter reflects a combination of pricing,
new customer wins, and expansion with our existing customers.
Adjusted EBITDA of $37.6 million declined 29.1% compared to the
first quarter of 2022 or 21.3% when adjusting for currency.
Adjusted EBITDA margin declined 330 basis points versus the first
quarter of 2022 due to cost pressures, partially offset by pricing
which is not yet fully realized. Acquisitions contributed $3.7
million to sales growth and $0.6 million to Adjusted EBITDA.
Food & Beverage
Unaudited |
First Quarter Ended March 31 |
(millions) |
|
2023 |
|
|
2022 |
|
% Change |
Net sales |
$ |
218.9 |
|
$ |
187.8 |
|
16.6 |
% |
Adjusted EBITDA |
|
25.7 |
|
|
22.1 |
|
16.3 |
% |
% Margin |
|
11.7 |
% |
|
11.8 |
% |
(10) bps |
Net sales of $218.9 million in the Food & Beverage segment
were 16.6% above the first quarter of 2022 or 25.8% when adjusting
for currency. This was driven by pricing, new customer wins and
continued success with the water treatment offering. Adjusted
EBITDA of $25.7 million increased 16.3% and margin declined 10
basis points compared to the first quarter of 2022. Adjusted EBITDA
increased 29.9% when adjusting for currency.
Take-Private Merger Agreement
On March 8, 2023, Diversey entered into an Agreement and Plan of
Merger (the “Merger Agreement”) with Olympus Water Holdings IV,
L.P. (acting by its General Partner, Olympus Water Holdings
Limited), and Diamond Merger Limited, pursuant to which Diamond
Merger Limited will be merged with and into Diversey with Diversey
continuing as the surviving company and as a wholly-owned
subsidiary of Olympus Water Holdings IV, L.P. (the “Merger”). If
the Merger is completed, Diversey’s ordinary shares will be removed
from listing on The Nasdaq Stock Market LLC and deregistered under
the Securities Exchange Act of 1934 and Diversey will no longer
file periodic reports with the Securities and Exchange Commission
(the “SEC”). Diversey expects the Merger to be completed in the
second half of 2023, subject to the satisfaction of certain
conditions, including the affirmative vote of holders of ordinary
shares representing at least two-thirds of the shares present and
voting in person or by proxy at the extraordinary general meeting
(the “Requisite Shareholder Approval”), the expiration of waiting
periods, receipt of certain other specified regulatory approvals,
and other customary closing conditions. In light of this
transaction, as is customary during the pendency of an acquisition,
Diversey will not be hosting an earnings conference call or live
webcast to discuss its first quarter 2023 financial results and
Diversey will not be providing guidance for 2023. For further
details and discussion of our financial performance please refer to
our Form 10-Q for the quarter ended March 31, 2023.
About Diversey
Diversey’s purpose is to go beyond clean to take care of what’s
precious through leading hygiene, infection prevention, and
cleaning solutions. We develop and deliver innovative products,
services, and technologies that save lives and protect our
environment. Over the course of 100 years, the Diversey brand has
become synonymous with product quality, service, and
innovation.
For more information about Diversey,
visit www.diversey.com or follow us on LinkedIn,
Facebook, or Twitter @diversey.
Diversey Holdings, Ltd.Investor Contact:Grant
Graverir@diversey.com
Cautionary Statements Regarding Forward-Looking
Information
This communication contains forward-looking statements that are
subject to substantial risks and uncertainties. All statements
other than statements of historical fact included in this
communication, including statements regarding the proposed Merger,
our business strategy, future operations and results thereof,
future financial position, future revenue, projected costs,
prospects, current and prospective products, current and
prospective collaborations, timing and likelihood of success, plans
and objectives of management, expected market growth and future
results of current and anticipated products are forward-looking
statements. You can identify forward-looking statements by the fact
that they do not relate strictly to historical or current facts.
These statements may include words such as “anticipate”,
“estimate”, “expect”, “project”, “plan”, "potential", "predict",
“intend”, “believe”, “may”, "might", “will”, "would", “should”,
“can have”, "could", "continue", "contemplate", "target", “likely”
and other words and terms of similar meaning in connection with any
discussion of the timing or nature of future operating or financial
performance or other events although not all forward-looking
statements contain these identifying words. For example, all
statements we make relating to the proposed Merger and its
completion, our estimated and projected costs, expenditures, cash
flows, growth rates and financial results or our plans and
objectives for future operations, growth initiatives, or strategies
are forward-looking statements. All forward-looking statements
involve unknown risks, and other important factors that may cause
actual results performance or achievements to be materially
different from any future results, performance or achievements
expressed or implied by the forward-looking statements,
including:
- uncertainties associated with the proposed Merger, including
the failure to complete the Merger in a timely manner or at all,
restrictions on business conduct and potential lawsuits related to
the proposed Merger;
- the occurrence of any event, change or other circumstances that
could give rise to the termination of the Merger Agreement;
- the inability to complete the proposed Merger due to the
failure to satisfy conditions precedent, including satisfaction of
the Requisite Shareholder Approval;
- risks related to disruption of management’s attention from our
ongoing business operations due to the proposed Merger;
- the effect of the announcement of the proposed Merger on our
relationships with our customers and on our operating results and
business generally;
- the costs of the proposed Merger if the proposed Merger is not
consummated;
- uncertain global economic conditions which have had and could
continue to have an adverse effect on our consolidated financial
condition and results of operations;
- the global nature of our operations exposes us to numerous
risks that could materially adversely affect our consolidated
financial condition and results of operations;
- fluctuations between non-U.S. currencies and the U.S. dollar
could materially impact our consolidated financial condition or
results of operations;
- political and economic instability and risk of government
actions affecting our business and our customers or suppliers may
adversely impact our business, results of operations and cash
flows;
- raw material pricing, availability and allocation by suppliers
as well as energy-related costs may negatively impact our results
of operations, including our profit margins;
- if we do not develop new and innovative products or if
customers in our markets do not accept them, our results would be
negatively affected;
- cyber risks and the failure to maintain the integrity of our
operational or security systems or infrastructure;
- the introduction of the Organization for Economic Cooperation
and Development’s Base Erosion and Profit Shifting may adversely
affect our effective rate of tax in future periods;
- the consolidation of customers may adversely affect our
business, consolidated financial condition or results of
operations;
- we experience competition in the markets for our products and
services and in the geographic areas in which we operate;
- instability and uncertainty in the credit and financial markets
could adversely impact the availability of credit that we and our
customers need to operate our business;
- new and stricter regulations may affect our business and
consolidated condition and results of operations; and
- the other risks described under “Risk Factors” in our Annual
Report on Form 10-K filed with the SEC.
We derive many of our forward-looking statements from our
operating budgets and forecasts, which are based on many detailed
assumptions. While we believe that our assumptions are reasonable,
we caution that it is very difficult to predict the impact of known
factors, and it is impossible for us to anticipate all factors that
could affect our actual results. All written and oral
forward-looking statements attributable to us, or persons acting on
our behalf, are expressly qualified in their entirety by these
cautionary statements as well as other cautionary statements that
are made from time to time in our other SEC filings and public
communications. You should evaluate all forward-looking statements
in the context of these risks and uncertainties.
We caution you that the important factors referenced above may
not contain all of the factors that are important to you. In
addition, we cannot assure you that we will realize the results or
developments we expect or anticipate or, even if substantially
realized, that they will result in the consequences or affect us or
our operations in the way we expect. The forward-looking statements
included herein are made only as of the date hereof. We undertake
no obligation to update or revise any forward-looking statement as
a result of new information, future events or otherwise, except as
otherwise required by law.
Non-GAAP Financial Information
We present financial information that conforms to generally
accepted accounting principles in the United States (“U.S. GAAP").
We also present financial information that does not conform to U.S.
GAAP ("Non-GAAP"), as our management believes it is useful to
investors.
The Non-GAAP financial metrics exclude items that we consider to
be certain specified items (“Special Items”), such as restructuring
charges, transaction and integration costs, certain transaction and
other charges related to acquisitions and divestitures, gains and
losses related to acquisitions and divestitures, and certain other
items. We evaluate unusual or Special Items on an individual basis.
Our evaluation of whether to exclude an unusual or Special Item for
purposes of determining our Non-GAAP financial measures considers
both the quantitative and qualitative aspects of the item,
including among other things (i) its nature, (ii) whether or not it
relates to our ongoing business operations, and (iii) whether or
not we expect it to occur as part of our normal business on a
regular basis.
EBITDA and Adjusted EBITDA
EBITDA and Adjusted EBITDA are supplemental measures that are
not required by, or presented in accordance with, U.S. GAAP. We
define EBITDA as income (loss) before income tax provisions
(benefit), interest expense, and depreciation and amortization, and
Adjusted EBITDA, as EBITDA adjusted for other items to (i)
eliminate certain non-operating income or expense items, (ii)
eliminate the impact of certain non-cash and other items that are
included in net income (loss) that we do not consider indicative of
our ongoing operating performance, and (iii) eliminate certain
unusual and non-recurring items impacting results in a particular
period.
EBITDA and Adjusted EBITDA are not measures of our financial
performance under U.S. GAAP and should not be considered as an
alternative to revenues, net income (loss), income (loss) before
income tax provision or any other performance measures derived in
accordance with U.S. GAAP, nor should they be considered as
alternatives to cash flows from operating activities as a measure
of liquidity in accordance with U.S. GAAP. In addition, our method
of calculating EBITDA and Adjusted EBITDA may vary from the methods
used by other companies.
Our management considers EBITDA and Adjusted EBITDA to be key
indicators of our financial performance. Additionally, we believe
EBITDA and Adjusted EBITDA are frequently used by securities
analysts, investors and other interested parties in the evaluation
of companies in our industry. We also believe that investors,
analysts and rating agencies consider EBITDA and Adjusted EBITDA
useful means of measuring our ability to meet our debt service
obligations and evaluating our financial performance, and
management uses these measures for one or more of these purposes.
Our presentation of EBITDA and Adjusted EBITDA should not be
construed as an inference that our future results will be
unaffected by unusual or nonrecurring items. EBITDA and Adjusted
EBITDA have important limitations as analytical tools and you
should not consider them in isolation or as a substitute for
analysis of our results as reported under U.S. GAAP. The use of
EBITDA and Adjusted EBITDA instead of net income has limitations as
an analytical tool.
Adjusted Net Income
Adjusted Net Income (as defined below) and Adjusted Earnings
(Loss) Per Share (“Adjusted EPS”) are Non-GAAP financial measures.
We define Adjusted Net Income as net income (loss) adjusted to (i)
eliminate certain non-operating income or expense items, (ii)
eliminate the impact of certain non-cash and other items that are
included in net income that we do not consider indicative of our
ongoing operating performance, (iii) eliminate certain unusual and
non-recurring items impacting results in a particular period, and
(iv) reflect the tax effect of items (i) through (iii) and other
tax special items. We define Adjusted EPS as our Adjusted Net
Income (Loss) divided by the number of weighted average shares
outstanding in the period.
We believe that in addition to our results determined in
accordance with GAAP, Adjusted Net Income and Adjusted EPS are
useful in evaluating our business, results of operations and
financial condition. We believe that Adjusted Net Income and
Adjusted EPS may be helpful to investors because they provide
consistency and comparability with past financial performance and
facilitate period to period comparisons of our operations and
financial results, as they eliminate the effects of certain
variables from period to period for reasons that we do not believe
reflect our underlying operating performance or are unusual or
infrequent in nature. However, Adjusted Net Income and Adjusted EPS
are presented for supplemental informational purposes only and
should not be considered in isolation or as a substitute or
alternative for financial information presented in accordance with
GAAP.
Adjusted Net Income and Adjusted EPS have limitations as
analytical tools.
Diversey Holdings,
Ltd.Condensed Consolidated Balance
Sheets(Unaudited)
(in
millions except per share amounts) |
March 31, 2023 |
December 31, 2022 |
Assets |
|
|
Current assets: |
|
|
|
Cash and cash equivalents |
$ |
125.7 |
|
$ |
205.6 |
|
|
Trade receivables, net of
allowance for doubtful accounts of $22.6 and $21.7 |
|
434.6 |
|
|
457.4 |
|
|
Other receivables |
|
77.4 |
|
|
77.1 |
|
|
Inventories |
|
405.5 |
|
|
354.6 |
|
|
Prepaid expenses and other
current assets |
|
114.6 |
|
|
110.6 |
|
|
Total current assets |
|
1,157.8 |
|
|
1,205.3 |
|
Property and
equipment, net |
|
260.2 |
|
|
254.1 |
|
Goodwill |
|
468.0 |
|
|
462.8 |
|
Intangible assets,
net |
|
1,985.0 |
|
|
1,984.1 |
|
Other non-current
assets |
|
339.3 |
|
|
348.4 |
|
|
Total assets |
$ |
4,210.3 |
|
$ |
4,254.7 |
|
|
|
|
|
Liabilities and stockholders' equity |
|
|
Current liabilities: |
|
|
|
Short-term borrowings |
$ |
1.1 |
|
$ |
3.8 |
|
|
Current portion of long-term
debt |
|
12.0 |
|
|
12.4 |
|
|
Accounts payable |
|
547.1 |
|
|
552.6 |
|
|
Accrued restructuring
costs |
|
22.7 |
|
|
28.0 |
|
|
Other current liabilities |
|
415.6 |
|
|
399.2 |
|
|
Total current liabilities |
|
998.5 |
|
|
996.0 |
|
Long-term debt,
less current portion |
|
1,965.8 |
|
|
1,969.0 |
|
Deferred
taxes |
|
148.8 |
|
|
148.6 |
|
Other non-current
liabilities |
|
468.4 |
|
|
468.1 |
|
|
Total liabilities |
|
3,581.5 |
|
|
3,581.7 |
|
Commitments and
contingencies |
|
|
Stockholders' equity: |
|
|
|
Ordinary shares, $0.01 par
value per share; 1,000,000,000 shares authorized, 324,683,350 and
324,328,774 shares outstanding in 2023 and 2022 |
|
— |
|
|
— |
|
|
Preferred shares, $0.0001 par
value per share, 200,000,000 shares authorized, 0 shares
outstanding in 2023 and 2022 |
|
— |
|
|
— |
|
|
Additional paid-in
capital |
|
1725.9 |
|
|
1,717.5 |
|
|
Accumulated deficit |
|
(943.0 |
) |
|
(889.4 |
) |
|
Accumulated other
comprehensive loss |
|
(154.1 |
) |
|
(155.1 |
) |
|
Total stockholders'
equity |
|
628.8 |
|
|
673.0 |
|
|
Total liabilities and stockholders' equity |
$ |
4,210.3 |
|
$ |
4,254.7 |
|
Diversey Holdings,
Ltd.Condensed Consolidated Statements of
Operations(Unaudited)
(in millions except
per share amounts) |
Three Months EndedMarch 31, 2023 |
Three Months EndedMarch 31, 2022 |
Net sales |
$ |
696.0 |
|
$ |
660.0 |
|
Cost of sales |
|
476.4 |
|
|
423.9 |
|
Gross profit |
|
219.6 |
|
|
236.1 |
|
Selling, general and
administrative expenses |
|
219.1 |
|
|
213.7 |
|
Transaction and integration
costs |
|
8.0 |
|
|
4.5 |
|
Amortization of intangible
assets |
|
21.9 |
|
|
24.2 |
|
Restructuring and exit
costs |
|
0.5 |
|
|
9.8 |
|
Operating loss |
|
(29.9 |
) |
|
(16.1 |
) |
Interest expense |
|
28.2 |
|
|
30.3 |
|
Foreign currency gain related
to hyperinflationary subsidiaries |
|
(3.1 |
) |
|
(0.3 |
) |
Other (income) expense,
net |
|
(10.7 |
) |
|
(8.9 |
) |
Loss before income tax provision |
|
(44.3 |
) |
|
(37.2 |
) |
Income tax provision |
|
9.3 |
|
|
1.9 |
|
Net loss |
$ |
(53.6 |
) |
$ |
(39.1 |
) |
|
|
|
Basic and diluted loss per
share |
$ |
(0.17 |
) |
$ |
(0.12 |
) |
Basic and diluted weighted
average shares outstanding |
|
323.2 |
|
|
319.6 |
|
Diversey Holdings,
Ltd.Condensed Consolidated Statements of Cash
Flows(Unaudited)
(in
millions) |
Three Months EndedMarch 31, 2023 |
Three Months EndedMarch 31, 2022 |
Operating
activities: |
|
|
|
Net loss |
$ |
(53.6 |
) |
$ |
(39.1 |
) |
|
Adjustments to reconcile net
loss to cash provided by (used in) operating activities: |
|
|
|
Depreciation and amortization |
|
43.4 |
|
|
47.4 |
|
|
Amortization of deferred financing costs and original issue
discount |
|
1.8 |
|
|
1.8 |
|
|
Gain on cash flow hedges |
|
1.1 |
|
|
1.1 |
|
|
Deferred taxes |
|
0.3 |
|
|
(3.5 |
) |
|
Unrealized foreign currency exchange gain |
|
(0.6 |
) |
|
(1.1 |
) |
|
Share-based compensation |
|
8.4 |
|
|
15.1 |
|
|
Impact of highly inflationary subsidiaries |
|
(3.1 |
) |
|
(0.3 |
) |
|
Provision for bad debts |
|
1.7 |
|
|
1.9 |
|
|
Provision for slow moving inventory |
|
2.9 |
|
|
0.4 |
|
|
Non-cash pension benefit |
|
(0.8 |
) |
|
(3.6 |
) |
|
Non-cash tax receivable agreement adjustments |
|
(4.9 |
) |
|
(6.4 |
) |
|
Gain on sale of property and equipment |
|
(3.7 |
) |
|
— |
|
|
Changes in operating assets and liabilities: |
|
|
|
Trade receivables, net |
|
21.7 |
|
|
3.0 |
|
|
Inventories, net |
|
(44.6 |
) |
|
(39.9 |
) |
|
Accounts payable |
|
(11.3 |
) |
|
68.3 |
|
|
Income taxes, net |
|
2.2 |
|
|
(4.6 |
) |
|
Other assets and liabilities, net |
|
(3.3 |
) |
|
5.4 |
|
Cash
provided by (used in) operating activities |
|
(42.4 |
) |
|
45.9 |
|
Investing
activities: |
|
|
|
Business acquired in purchase transactions, net of cash
acquired |
|
(11.7 |
) |
|
(41.4 |
) |
|
Proceeds from sale of property and equipment and other assets |
|
6.2 |
|
|
— |
|
|
Dosing and dispensing equipment |
|
(18.4 |
) |
|
(17.3 |
) |
|
Capital expenditures |
|
(6.1 |
) |
|
(10.0 |
) |
Cash used
in investing activities |
|
(30.0 |
) |
|
(68.7 |
) |
Financing
activities: |
|
|
|
Payments on short-term borrowings |
|
(2.5 |
) |
|
(7.2 |
) |
|
Proceeds from revolving credit facility |
|
20.0 |
|
|
50.0 |
|
|
Payments on revolving credit facility |
|
(20.0 |
) |
|
(50.0 |
) |
|
Payments on long-term borrowings |
|
(5.2 |
) |
|
(4.3 |
) |
|
Proceeds from derivatives |
|
— |
|
|
45.3 |
|
Cash
provided by (used in) financing activities |
|
(7.7 |
) |
|
33.8 |
|
Effect of exchange
rate changes on cash and cash equivalents |
|
0.2 |
|
|
(2.4 |
) |
|
Increase (decrease) in cash and cash equivalents |
|
(79.9 |
) |
|
8.6 |
|
Cash and cash
equivalents at beginning of period |
|
206.2 |
|
|
208.2 |
|
Cash, cash
equivalents and restricted cash at end of period |
$ |
126.3 |
|
$ |
216.8 |
|
|
|
|
Supplemental Cash
Flow Information: |
|
|
|
Interest payments |
$ |
22.0 |
|
$ |
25.3 |
|
|
Income tax payments |
$ |
4.9 |
|
$ |
9.8 |
|
The following table reconciles loss before income tax provision
to EBITDA and Adjusted EBITDA for the periods presented:
(in
millions) |
Three Months EndedMarch 31, 2023 |
Three Months EndedMarch 31, 2022 |
Loss before income tax provision |
$ |
(44.3 |
) |
$ |
(37.2 |
) |
Interest expense |
|
28.2 |
|
|
30.3 |
|
Interest income |
|
(1.7 |
) |
|
(0.7 |
) |
Amortization expense of
intangible assets |
|
21.9 |
|
|
24.2 |
|
Depreciation expense included
in cost of sales |
|
19.9 |
|
|
20.6 |
|
Depreciation expense included
in selling, general and administrative expenses |
|
1.6 |
|
|
2.6 |
|
EBITDA |
|
25.6 |
|
|
39.8 |
|
Transaction and integration
costs(1) |
|
8.0 |
|
|
4.5 |
|
Restructuring and exit
costs(2) |
|
0.5 |
|
|
9.8 |
|
Other costs related to
facilities consolidations(3) |
|
18.1 |
|
|
— |
|
Foreign currency gain related
to hyperinflationary subsidiaries(4) |
|
(3.1 |
) |
|
(0.3 |
) |
Adjustment for tax
indemnification asset(5) |
|
— |
|
|
(0.1 |
) |
Acquisition accounting
adjustments(6) |
|
— |
|
|
1.3 |
|
Non-cash pension and other
post-employment benefit plan(7) |
|
(0.8 |
) |
|
(3.6 |
) |
Unrealized foreign currency
exchange gain(8) |
|
(0.6 |
) |
|
(1.1 |
) |
Securitization fees(9) |
|
2.4 |
|
|
0.9 |
|
Share-based
compensation(10) |
|
11.0 |
|
|
15.1 |
|
Tax receivable agreement
adjustments(11) |
|
(4.9 |
) |
|
(6.4 |
) |
Gain on sale of property and
equipment(12) |
|
(3.7 |
) |
|
— |
|
Other items |
|
0.1 |
|
|
0.4 |
|
Consolidated Adjusted
EBITDA |
$ |
52.6 |
|
$ |
60.3 |
|
The following table reconciles net loss to Adjusted Net Income
and basic and diluted earnings (loss) per share to Adjusted EPS for
the periods presented:
|
Three Months EndedMarch 31, 2023 |
Three Months EndedMarch 31, 2022 |
(in millions, except
per share amounts) |
Net Income(Loss) |
Basic anddiluted EPS |
Net Income(Loss) |
Basic anddiluted EPS |
Reported (GAAP) |
$ |
(53.6 |
) |
$ |
(0.17 |
) |
$ |
(39.1 |
) |
$ |
(0.12 |
) |
Amortization expense of
intangible assets acquired |
|
21.9 |
|
|
0.07 |
|
|
24.2 |
|
|
0.08 |
|
Transaction and integration
costs(1) |
|
8.0 |
|
|
0.02 |
|
|
4.5 |
|
|
0.01 |
|
Restructuring and exit
costs(2) |
|
0.5 |
|
|
0.00 |
|
|
9.8 |
|
|
0.03 |
|
Other costs related to
facilities consolidations(3) |
|
18.1 |
|
|
0.06 |
|
|
— |
|
|
— |
|
Foreign currency gain related
to hyperinflationary subsidiaries(4) |
|
(3.1 |
) |
|
(0.01 |
) |
|
(0.3 |
) |
|
0.00 |
|
Adjustment for tax
indemnification asset(5) |
|
— |
|
|
— |
|
|
(0.1 |
) |
|
0.00 |
|
Acquisition accounting
adjustments(6) |
|
— |
|
|
— |
|
|
1.3 |
|
|
0.00 |
|
Non-cash pension and other
post-employment benefit plan(7) |
|
(0.8 |
) |
|
0.00 |
|
|
(3.6 |
) |
|
(0.01 |
) |
Unrealized foreign currency
exchange gain(8) |
|
(0.6 |
) |
|
0.00 |
|
|
(1.1 |
) |
|
0.00 |
|
Share-based
compensation(10) |
|
11.0 |
|
|
0.03 |
|
|
15.1 |
|
|
0.05 |
|
Tax receivable agreement
adjustments(11) |
|
(4.9 |
) |
|
(0.02 |
) |
|
(6.4 |
) |
|
(0.02 |
) |
Gain on sale of property and
equipment(12) |
|
(3.7 |
) |
|
(0.01 |
) |
|
— |
|
|
— |
|
Other items |
|
0.1 |
|
|
0.00 |
|
|
0.4 |
|
|
0.00 |
|
Tax effects related to
non-GAAP adjustments(13) |
|
(10.9 |
) |
|
(0.03 |
) |
|
(10.5 |
) |
|
(0.04 |
) |
Discrete tax
adjustments(14) |
|
19.5 |
|
|
0.06 |
|
|
9.5 |
|
|
0.03 |
|
Adjusted
(Non-GAAP) |
$ |
1.5 |
|
$ |
0.00 |
|
$ |
3.7 |
|
$ |
0.01 |
|
(1) These costs consist primarily of
professional and consulting services which are non-operational in
nature, costs related to strategic initiatives, acquisition-related
costs, costs incurred in preparing to become a publicly traded
company, and costs related to the Merger.
(2) Includes costs related to restructuring
programs and business exit activities. Refer to Note 16 —
Restructuring and Exit Activities in the Notes to our Condensed
Consolidated Financial Statements included elsewhere in our
Quarterly Report on Form 10-Q for additional information.
(3) Represents other costs related to
consolidating certain manufacturing and warehousing facilities
within Europe and North America, which are non-recurring and
included in Cost of Sales in our Condensed Consolidated Statements
of Operations.
(4) Argentina and Turkey were deemed to have
highly inflationary economies and the functional currencies for our
Argentina and Turkey operations were changed from the Argentine
peso and Turkish lira to the U.S. dollar and remeasurement
charges/credits are recorded in our Condensed Consolidated
Statements of Operations rather than as a component of Cumulative
Translation Adjustment on our Condensed Consolidated Balance
Sheets.
(5) In connection with the original acquisition
of the Diversey business in 2017, the purchase agreement governing
the transaction includes indemnification provisions with respect to
tax liabilities. The offset to this adjustment is included in
income tax provision.
(6) In connection with various acquisitions we
recorded fair value increases to our inventory. These amounts
represent the amortization of this increase.
(7) Represents the net impact of the expected
return on plan assets, interest cost, and settlement cost
components of net periodic defined benefit income related to our
defined benefit pension plans.
(8) Represents the unrealized foreign currency
exchange impact on our operations, primarily attributed to the
valuation of the U.S. Dollar-denominated debt held by our European
entity.
(9) Represents the fees to complete the sale of
the receivables without recourse under our accounts receivable
securitization agreements. Refer to Note 5 — Financial Statement
Details in the Notes to our Condensed Consolidated Financial
Statements included elsewhere in our Quarterly Report on Form 10-Q
for additional information.
(10) Represents compensation expense associated
with our share-based equity and liability awards. See Note 15 —
Share-Based Compensation in the Notes to our Condensed Consolidated
Financial Statements included elsewhere in our Quarterly Report on
Form 10-Q for additional information.
(11) Represents the adjustment to our tax
receivable agreement liability due to changes in valuation
allowances that impact the realizability of the attributes of the
tax receivable agreement.
(12) Represents the gain on sale of property and
equipment, primarily attributed to the sale of certain
facilities.
(13) The tax rate used to calculate the tax
impact of the pre-tax adjustments is based on the jurisdiction in
which the charge was recorded.
(14) Represents adjustments related to discrete
tax items including uncertain tax provisions, impacts from rate
changes in certain jurisdictions and changes in our valuation
allowance.
The following table represents net sales by
segment:
(in millions, except
percentages) |
Institutional |
Food & Beverage |
Total |
First Quarter 2022 Net
Sales |
$ |
472.2 |
|
71.5 |
% |
$ |
187.8 |
|
28.5 |
% |
$ |
660.0 |
|
|
Organic change (non-U.S. GAAP) |
|
31.0 |
|
6.6 |
% |
|
48.4 |
|
25.8 |
% |
|
79.4 |
|
12.0 |
% |
Acquisition |
|
3.7 |
|
0.8 |
% |
|
— |
|
— |
% |
|
3.7 |
|
0.6 |
% |
Constant dollar change
(non-U.S. GAAP) |
|
34.7 |
|
7.3 |
% |
|
48.4 |
|
25.8 |
% |
|
83.1 |
|
12.6 |
% |
Foreign currency
translation |
|
(29.8 |
) |
(6.3 |
)% |
|
(17.3 |
) |
(9.2)% |
|
(47.1 |
) |
(7.1)% |
Total change |
|
4.9 |
|
1.0 |
% |
|
31.1 |
|
16.6 |
% |
|
36.0 |
|
5.5 |
% |
First Quarter 2023 Net
Sales |
$ |
477.1 |
|
68.5 |
% |
$ |
218.9 |
|
31.5 |
% |
$ |
696.0 |
|
|
Diversey (NASDAQ:DSEY)
Historical Stock Chart
From Oct 2024 to Nov 2024
Diversey (NASDAQ:DSEY)
Historical Stock Chart
From Nov 2023 to Nov 2024